50264-84-1

Basic information

• Product Name: 1H-Indazole-3-carboxylic acid, 1-[(2,4-dichlorophenyl)methyl]-, ethyl ester
• CAS NO: 50264-84-1
• Molecular Formula: C17H14Cl2N2O2
• Molecular Weight: 349.216
• Mol File: 50264-84-1.mol
• Article Data: 2

Chemical Properties

• CAS DataBase Reference: 1H-Indazole-3-carboxylic acid, 1-[(2,4-dichlorophenyl)methyl]-, ethyl ester(CAS DataBase Reference)
• NIST Chemistry Reference: 1H-Indazole-3-carboxylic acid, 1-[(2,4-dichlorophenyl)methyl]-, ethyl ester(50264-84-1)
• EPA Substance Registry System: 1H-Indazole-3-carboxylic acid, 1-[(2,4-dichlorophenyl)methyl]-, ethyl ester(50264-84-1)

Safety Data

• Hazardous Substances Data: 50264-84-1(Hazardous Substances Data)

Upstream product

• 64-17-5 ethanol 
• 50264-69-2 lonidamine 

Relevant articles and documents

MODIFICATIONS OF THERAPEUTIC AGENTS FOR ENHANCED DELIVERY TO TARGET SITES

Compositions of a modulator of cell metabolism, typically targeting cellular glycolysis, preferably with a targeting moiety, attached directly or indirectly to the inhibitor, or to a nanoparticle or other delivery vehicle thereof, and methods of use for treating cancer, proliferative disorders, neurodegenerative diseases, autoimmune disorders, or inflammatory diseases are provided. Pharmaceutical compositions including the targeted modulator and a pharmaceutically acceptable carrier are also provided. The pharmaceutical compositions can be administered to a subject in need thereof in an effective amount to reduce one or symptoms of the cancer, proliferative disorders, neurodegenerative diseases, autoimmune disorders, or inflammatory diseases alone or prior to or in conjunction with a further therapy such as radiotherapy.